Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset

Rhea-AI Summary

Basel Medical Group (Nasdaq: BMGL) has announced the temporary suspension of its planned Bitcoin (BTC) digital asset acquisition. The decision was reached mutually between Basel and the consortium of Bitcoin holders due to regulatory uncertainties in the United States.

The pause comes amid ongoing regulatory review of digital assets by US authorities and unclear forthcoming policies that could impact the transaction. Both parties have agreed to reassess the opportunity once there is greater regulatory clarity in the digital asset space.

Positive

• Demonstrates prudent risk management by pausing during regulatory uncertainty
• Maintains flexibility to reassess the deal when regulatory environment clarifies

Negative

• Delay in strategic digital asset acquisition plans
• Potential loss of opportunity if market conditions or prices change significantly
• Uncertainty around timeline for deal completion due to regulatory concerns

Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the consortium of Bitcoin (BTC) holders have mutually agreed to pause the acquisition of digital asset. This decision reflects the ongoing regulatory review of digital assets by US authorities and the current lack of clarity on how forthcoming policies may impact the transaction.

Given these uncertainties, both parties believe it is prudent to defer the deal until there is greater regulatory certainty. We will continue to monitor developments closely and reassess the opportunity once the regulatory landscape becomes clearer.

About Basel Medical Group Ltd

Basel Medical is a Singapore-based provider of orthopedic and trauma services, sports medicine and surgery, orthopedic procedures, as well as neurosurgical treatments. Our operations are based in Singapore, with our clinics being at 6 Napier Road, Unit #02-10/11 and Unit #03-07, Gleneagles Medical Centre. Over the last 20 years, our group has forged strong and lasting relationships with a large base of corporations, in particular those in the construction, marine and oil & gas industries, which underpin our robust business model. As an orthopedic service provider in Singapore with a track record of over 20 years, we are well-positioned to ride the wave of growth opportunities in the private healthcare industry in Singapore and across Southeast Asia driven by ageing populations, rising income levels, increasing private insurance coverage, government effort and expenditure on healthcare, growing sports participation rate and Singapore’s position as a premium destination for healthcare services in Asia. Our management and medical practitioner team comprises a roster of orthopedic and neurosurgery specialists, corporate finance and healthcare partnership specialists. Basel Medical Group Ltd serves as the holding company of our group and we conduct our operations through our operating subsidiaries based in Singapore. For more information, please visit the Company’s website: www.baselmedical.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, which involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “aim”, “anticipate”, “believe”, “estimate”, “expect”, “going forward”, “intend”, “may”, “plan”, “potential”, “predict”, “propose”, “seek”, “should”, “will”, “would” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s filings with the SEC.

Media Contact:

Basel Medical Group Ltd
+65 6291 9188
contact@baselmedical.com
www.baselmedical.com

FAQ

Why did Basel Medical Group (BMGL) put their Bitcoin acquisition on hold?

Basel Medical Group paused the Bitcoin acquisition due to ongoing regulatory review of digital assets by US authorities and uncertainty about how forthcoming policies may impact the transaction.

What is the current status of Basel Medical Group's (BMGL) Bitcoin deal?

The Bitcoin acquisition deal has been temporarily put on hold by mutual agreement between Basel Medical Group and the consortium of Bitcoin holders.

Will Basel Medical Group (BMGL) proceed with the Bitcoin acquisition in the future?

The company stated they will continue monitoring developments and reassess the opportunity once the regulatory landscape becomes clearer.

How does the regulatory uncertainty affect BMGL's Bitcoin acquisition plans?

The regulatory uncertainty has led to a temporary suspension of the deal, as both parties want to ensure compliance with potential new US policies regarding digital assets.

What impact does the Bitcoin deal suspension have on Basel Medical Group (BMGL)?

The suspension demonstrates BMGL's cautious approach to regulatory compliance but delays their strategic entry into digital assets until there is more regulatory clarity.